Adoption of Telemedicine to Benefit COVID-19 Diagnostics Market

Global COVID-19 Diagnostics Market: Information by Type (Molecular Tests, Serology Tests), Technology (RT-PCR, Isothermal Amplification, CRISPR, ELISA, Hybridization), End-User (Hospitals, Public Health Labs, Private or Commercial Labs) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast till 2027

Market Overview

Market Research Future (MRFR) studied the global COVID 19 diagnostics market 2021 through the analysis period till 2027. As per MRFR study, the COVID 19 diagnosis market is likely to register 6.28% CAGR in the review period. By 2027, the COVID 19 diagnostics market value can touch USD 96,293.9 Mn.

Market Drivers and Restraints

The expansion of the COVID 19 diagnostics market can be attributed to the surge in government initiatives targeted toward mass testing. The rise in demand for mobile testing is also likely to open new avenues for COVID 19 diagnostics market. The introduction of at-home testing solutions with the availability of advanced software that can boost patient convenience can contribute to the market rise. As new strains of COVID 19 are observed to emerge across different regions registering a significant rise in COVID 19 cases, the need for COVID-19 diagnostic products is increasing. This can also add to the market expansion. The tourism and travel sector is impacted severely due to the pandemic outbreak. The rise in testing programs can pave the way for the travel industry to resume its business by creating a favorable environment for people to travel safely. The growing adoption of telemedicine solutions can improve the impetus of the market in the years ahead.

Request Free Sample Copy at:  https://www.marketresearchfuture.com/sample_request/9710 

Segment Analysis

The segment assessment of the global COVID-19 diagnostics market is based on type, end users, and technology.

The type-based segments of the COVID 19 diagnostics market are serology tests and molecular tests. The high prevalence of serology tests can prompt the market expansion in the near future. The growing traction for molecular tests can also benefit the market.

The technology-based segments of the COVID 19 diagnostics market are CRISPR, RT-PCR, ELISA, isothermal amplification, and hybridization among others. The increase in prominence of CRISPR is likely to indicate the high expansion rate of the market in the foreseeable future. The RT-PCR segment is also expected to gain high revenue for the market.

The end-user-based segments of the COVID-19 diagnostics market are private or commercial labs, hospitals, and public health labs among others.

Regional Analysis

In Europe, the COVID-19 diagnostics market expansion can be attributed to the rise in morbidity and mortality rate in the region due to the pandemic. The increasing demand for long-term care facilities (LTCF) in EU and EEA regions for the prevention and control of the pandemic is observed to increase the demand for COVID 19 diagnostic aid. The large-scale availability of diagnostics solutions for the immediate detection of COVID-19 cases can favor the EU market in the near future. Moreover, the increasing support from private and public organizations for handling COVID-19 is likely to add to the market upsurge in the Europe region.

In the Americas, the COVID 19 diagnostics market is likely to secure the second largest share of the worldwide market, after Europe during the forecast tenure. The surge in product launches by top-notch players and the ongoing effort by public organizations to control the spread of SARS-CoV-2 virus is anticipated to drive the COVID 19 diagnostic market in the Americas. In addition, a sudden surge in count of corona virus-positive cases can boost the sales of diagnostic tools, which, in turn, can benefit the regional market.

In Asia Pacific, the COVID 19 diagnostics market is likely to register a decent CAGR in the review period. The rapid surge in the number of cases leading governments and private laboratories to ramp-up testings can boost the regional COVID 19 diagnostics market in the years to come.

The COVID 19 diagnostics market in the Middle East & Africa region is likely to experience steady growth. Regions, such as; Kuwait, Saudi Arabia, and the UAE, are witnessing an upsurge in COVID-19 cases, encouraging governments to improve patient care solutions and services, which, in turn, can work in favor MEA market.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/covid-19-diagnostics-market-9710 

Key Players

MRFR enlisted some reputed companies in the worldwide COVID-19 diagnostics market. They are; Danaher Corporation (US), Becton, Abbott (US), F. Hoffmann-La Roche Ltd (Switzerland), Dickinson & Company (US), Bio-Rad Laboratories (US), Genmark Diagnostics (US), Biomerieux SA (France), Siemens AG (Germany), Thermo Fisher Scientific (US), and Qiagen (Germany).

You may also be interested in..

Fibromyalgia Treatments Market Research Report- Global Forecast To 2027

Digital pathology Market Research Report- Global Forecast To 2027

Global Intra-cranial pressure (ICP) monitor  Market Research Report- Forecast To 2027

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Article source: https://article-realm.com/article/Finance/14703-Adoption-of-Telemedicine-to-Benefit-COVID-19-Diagnostics-Market.html